AC Immune (ACIU) Revenue (2014 - 2026)

AC Immune (ACIU) posted quarterly Revenue of $1.4 million for Q1 2026, up 29.77% year-over-year from $1.1 million in Q1 2025, and up 237.9% quarter-over-quarter from $422895.4 in Q4 2025.

AC Immune (ACIU) Revenue (2014 - 2026) Analysis & Trends

AC Immune (ACIU) has reported Revenue for 11 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Revenue rose 29.77% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $4.6 million (down 85.87% YoY), while the FY2025 annual figure was $4.3 million, down 86.18% from the prior year.
  • Revenue grew to $1.4 million in Q1 2026 per ACIU's latest filing, from $422895.4 in the prior quarter.
  • Across five years, Revenue topped out at $29.4 million in Q3 2024 and bottomed at $36330.8 in Q4 2022.
  • Historically, Revenue has averaged $4.1 million across 4 years, with a median of $1.2 million in 2024.
  • On a YoY basis, Revenue climbed as much as 107.65% in 2025 and fell as far as 96.01% in 2025.
  • AC Immune's Revenue stood at $36330.8 in 2022, then surged by 3472.48% to $1.3 million in 2024, then plunged by 67.42% to $422895.4 in 2025, then surged by 237.9% to $1.4 million in 2026.
  • Business Quant data shows ACIU's Revenue at $1.4 million in Q1 2026, $422895.4 in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 AC Immune 253.89 Mn 253.89 Mn - 19.12 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 19.12 Mn
Mar 31, 2026 1.43 Mn
Dec 31, 2025 422,895.39
Sep 30, 2025 1.17 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 29.41 Mn
Jun 30, 2024 759,680.13
Dec 31, 2022 36,330.77
Sep 30, 2022 4.04 Mn
Dec 31, 2020 1.04 Mn
Sep 30, 2020 1.22 Mn
Jun 30, 2020 1.12 Mn
Mar 31, 2020 12.70 Mn
Dec 31, 2019 868,929.92
Sep 30, 2019 2.23 Mn
Jun 30, 2019 1.51 Mn
Mar 31, 2019 75.35 Mn
Dec 31, 2018 1.13 Mn